BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Diiodotyrosine

A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE).

300+ PubMed studies analyzed · Evidence Score: 43.6

Research Domains

Diiodotyrosine has been studied across 14 research domains including 🧬 Hormones, 🫁 Liver & Detox, 🧠 Focus & Attention, 🫘 Kidney, 🌤️ Mood & Depression. The primary research focus is 🧬 Hormones with 52% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Diiodotyrosine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carmine
8 shared targets
Levodopa
9 shared targets
Cisplatin
8 shared targets
iodoform
5 shared targets
Methyldopa
11 shared targets
tiopronin
3 shared targets
Dimethylphenylpiperazinium
5 shared targets
gamma-Linolenic
5 shared targets
Demeclocycline
7 shared targets
Ethidium
14 shared targets
Loading evidence profile...

This evidence profile for Diiodotyrosine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.